{
    "accessibility": "Open access (with restrictions)",
    "additionDate": "2021-12-20T21:14:21.953829Z",
    "biotoolsCURIE": "biotools:nicedrug.ch",
    "biotoolsID": "nicedrug.ch",
    "confidence_flag": "tool",
    "cost": "Free of charge",
    "credit": [
        {
            "email": "vassily.hatzimanikatis@epfl.ch",
            "name": "Vassily Hatzimanikatis",
            "orcidid": "https://orcid.org/0000-0001-6432-4694",
            "typeEntity": "Person"
        },
        {
            "name": "Noushin Hadadi",
            "orcidid": "https://orcid.org/0000-0001-6614-4910"
        },
        {
            "name": "Jasmin Hafner",
            "orcidid": "https://orcid.org/0000-0002-1474-5869"
        },
        {
            "name": "Kiandokht Haddadi",
            "orcidid": "https://orcid.org/0000-0001-5950-9571"
        },
        {
            "name": "Anush Chiappino-Pepe",
            "orcidid": "https://orcid.org/0000-0002-3993-907X"
        },
        {
            "name": "Homa MohammadiPeyhani",
            "orcidid": "https://orcid.org/0000-0002-1308-4659"
        }
    ],
    "description": "NICEdrug.ch is a resource allowing systematic and large-scale computational analysis of drug biochemistry (metabolic precursors or prodrugs and metabolic fate or degradation), enzymatic targets, and toxicity in the context of cellular metabolism, i.e. currently including: human, Plasmodium (malaria parasite), and E. coli metabolism.",
    "editPermission": {
        "type": "private"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "Small molecule design",
                    "uri": "http://edamontology.org/operation_4009"
                },
                {
                    "term": "Metabolic network modelling",
                    "uri": "http://edamontology.org/operation_3660"
                },
                {
                    "term": "Metabolic pathway prediction",
                    "uri": "http://edamontology.org/operation_3929"
                },
                {
                    "term": "Visualisation",
                    "uri": "http://edamontology.org/operation_0337"
                },
                {
                    "term": "Scaffolding",
                    "uri": "http://edamontology.org/operation_3216"
                }
            ]
        }
    ],
    "homepage": "https://lcsb-databases.epfl.ch/pathways/Nicedrug/",
    "lastUpdate": "2021-12-20T21:14:21.956322Z",
    "license": "Not licensed",
    "name": "NICEdrug.ch",
    "operatingSystem": [
        "Mac",
        "Linux",
        "Windows"
    ],
    "owner": "Jennifer",
    "publication": [
        {
            "doi": "10.7554/ELIFE.65543",
            "metadata": {
                "abstract": "\u00a9 MohammadiPeyhani et al.The discovery of a drug requires over a decade of intensive research and financial investments \u2013 and still has a high risk of failure. To reduce this burden, we developed the NICEdrug.ch resource, which incorporates 250,000 bioactive molecules, and studied their enzymatic metabolic targets, fate, and toxicity. NICEdrug.ch includes a unique fingerprint that identifies reactive similarities between drug\u2013drug and drug\u2013metabolite pairs. We validated the application, scope, and performance of NICEdrug.ch over similar methods in the field on golden standard datasets describing drugs and metabolites sharing reactivity, drug toxicities, and drug targets. We use NICEdrug.ch to evaluate inhibition and toxicity by the anticancer drug 5-fluorouracil, and suggest avenues to alleviate its side effects. We propose shikimate 3-phosphate for targeting liver-stage malaria with minimal impact on the human host cell. Finally, NICEdrug.ch suggests over 1300 candidate drugs and food molecules to target COVID-19 and explains their inhibitory mechanism for further experimental screening. The NICEdrug.ch database is accessible online to systematically identify the reactivity of small molecules and druggable enzymes with practical applications in lead discovery and drug repurposing.",
                "authors": [
                    {
                        "name": "Mohammadipeyhani H."
                    },
                    {
                        "name": "Chiappino-Pepe A."
                    },
                    {
                        "name": "Haddadi K."
                    },
                    {
                        "name": "Hafner J."
                    },
                    {
                        "name": "Hadadi N."
                    },
                    {
                        "name": "Hatzimanikatis V."
                    }
                ],
                "citationCount": 1,
                "date": "2021-01-01T00:00:00Z",
                "journal": "eLife",
                "title": "Nicedrug.Ch, a workflow for rational drug design and systems-level analysis of drug metabolism"
            },
            "pmcid": "PMC8331181",
            "pmid": "34340747"
        }
    ],
    "toolType": [
        "Database portal",
        "Workflow"
    ],
    "topic": [
        {
            "term": "Drug metabolism",
            "uri": "http://edamontology.org/topic_3375"
        },
        {
            "term": "Endocrinology and metabolism",
            "uri": "http://edamontology.org/topic_3407"
        },
        {
            "term": "Medicinal chemistry",
            "uri": "http://edamontology.org/topic_0209"
        },
        {
            "term": "Small molecules",
            "uri": "http://edamontology.org/topic_0154"
        },
        {
            "term": "Metabolomics",
            "uri": "http://edamontology.org/topic_3172"
        }
    ]
}